TAK1-Mediated Serine/Threonine Phosphorylation of Epidermal Growth Factor Receptor via p38/Extracellular Signal-Regulated Kinase: NF-kappa B-Independent Survival Pathways in Tumor Necrosis Factor Alpha Signaling

[摘要]：The kinase TAK1, a mitogen-activated protein kinase kinase kinase (MAP3K),has been widely accepted as a key kinase activating NF-kappa B and MAPKs in tumor necrosis factor alpha (TNF-alpha) signaling. We have recently reported that TAK1 regulates the transient phosphorylation and endocytosis of epidermal growth factor receptor (EGFR) in a tyrosine kinase activity-independent manner. In the present study, we found that Thr-669 in the juxtamembrane domain and Ser-1046/1047 in the carboxyl-terminal regulatory domain were transiently phosphorylated in response to TNF-alpha. Experiments using chemical inhibitors and small interfering RNA demonstrated that TNF-alpha-mediated phosphorylation of Thr-669 and Ser-1046/7 were differently regulated via TAK1-extracellular signal-regulated kinase (ERK) and TAK1-p38 pathways, respectively. In addition, p38, but not ERK, was involved in the endocytosis of EGFR. Surprisingly, modified EGFR was essential to prevent apoptotic cellular responses; however, the EGFR pathway was independent of the NF-kappa B antiapoptotic pathway. These results demonstrated that TAK1 controls two different signaling pathways, I kappa B kinase-NF-kappa B and MAPK-EGFR, leading to the survival of cells exposed to the death signal from the TNF-alpha receptor.

[全文传递流程]：

一般上传文献全文的时限在1个工作日内